Dental DSO Offer Calculator & Analyzer

DSO offers look bigger than private offers. That's the point. Behind the headline number is a stack of earnouts, equity rollovers, production guarantees, and holdbacks that dilute what you actually take home — sometimes by 40% or more. The DSO Offer Analyzer breaks any offer down into its real components and tells you what you'll actually receive, and when.

How DSO Offers Actually Work

A typical DSO offer quotes a total enterprise value. That number is rarely what changes hands at closing. Expect a structure like this: 60% to 75% cash at close, which is the only part that functions like a traditional sale. 15% to 25% equity rollover — units in the parent platform that are illiquid and only turn to cash at a recap event when the DSO sells to the next-tier buyer, typically three to seven years out, sometimes never. 5% to 15% earnout paid if the practice hits production, collections, or EBITDA targets over two to four years post-close. Miss the targets and the earnout shrinks or disappears.

On top of that, a production guarantee or compensation adjustment ties your ongoing salary to hitting specific numbers. If your production dips below a threshold, your comp drops. If you want to cut hours or retire early, your income drops.

Stack these components and a headline $1.8M offer can become $1.1M of actual cash over five years if the equity doesn't recap and the earnout targets slip.

What the Analyzer Tells You

Enter the offer terms and get guaranteed cash at close, probability-adjusted expected value of the earnout, risk-adjusted expected value of the equity rollover, all-in expected net after taxes and fees, comparison to a private-sale equivalent, and red flags specific to the structure you're being offered.

When a DSO Offer Is Good

Not all DSO offers are bad. For some sellers — younger dentists who want to stay five to seven more years, sellers in consolidating specialties, practices with real platform value — DSO deals legitimately clear more total dollars than private sales. The analyzer is built to tell you which scenario you're in, not to steer you one direction.

Frequently Asked Questions

Is equity rollover a scam?

No, but it's misunderstood. When it works, it can 2x-4x total proceeds at a recap. When it doesn't, the equity is worth what you paid for it — which was nothing, because it was part of your sale. You need to model both outcomes to know what you're actually accepting.

How do I know if earnout targets are achievable?

Compare them to your trailing three-year trajectory. If targets require 8% year-over-year growth and you've averaged 3%, the earnout is a negotiating chip the DSO is using to pad the headline. Ask to see how other practices in the platform have performed on their earnouts — serious DSOs will share.

What's the recap timeline I should plan around?

Three to seven years is typical. Ask the DSO directly: when did the current PE sponsor invest, and what's their target hold period? Back into when your equity is likely to become liquid. If the sponsor just invested, you're early and the timeline is long.

Can I negotiate DSO offer structure?

Often more than sellers realize. Increasing cash at close and decreasing earnout is the most common trade. Some DSOs will also accept a shorter production commitment or a higher compensation floor.

Is private sale always better for a seller planning to retire soon?

Usually, yes. If you want out in twelve months, DSO structures that tie your compensation to production don't fit. Private sale is cleaner.

What's the biggest mistake sellers make with DSO offers?

Optimizing for the headline number. Always. The headline is the marketing. The terms are the deal.